-
1
-
-
33745834319
-
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
-
Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006: 116: 1784.
-
(2006)
J Clin Invest
, vol.116
, pp. 1784
-
-
Kadowaki, T.1
Yamauchi, T.2
Kubota, N.3
Hara, K.4
Ueki, K.5
Tobe, K.6
-
2
-
-
33748086764
-
Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease
-
Gable DR, Hurel SJ, Humphries SE. Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease. Atherosclerosis 2006: 188: 231.
-
(2006)
Atherosclerosis
, vol.188
, pp. 231
-
-
Gable, D.R.1
Hurel, S.J.2
Humphries, S.E.3
-
3
-
-
34547670824
-
The effect of renal transplantation on adiponectin and its isoforms and receptors
-
Shen YY, Charleswoth JA, Kelly JJ, Peake PW. The effect of renal transplantation on adiponectin and its isoforms and receptors. Metabolism 2007: 56: 1201.
-
(2007)
Metabolism
, vol.56
, pp. 1201
-
-
Shen, Y.Y.1
Charleswoth, J.A.2
Kelly, J.J.3
Peake, P.W.4
-
4
-
-
43849094941
-
Prevalence of metabolic syndrome in long-term survivors of hematopoietic stem cell transplantation
-
Annaloro C, Usardi P, Airaghi L et al. Prevalence of metabolic syndrome in long-term survivors of hematopoietic stem cell transplantation. Bone Marrow Transplant 2008: 41: 797.
-
(2008)
Bone Marrow Transplant
, vol.41
, pp. 797
-
-
Annaloro, C.1
Usardi, P.2
Airaghi, L.3
-
5
-
-
1842864234
-
Plasma adiponectin levels and risk of myocardial infarction in men
-
Pischon T, Girman CJ, Hotamisligil G, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004: 291: 1730.
-
(2004)
JAMA
, vol.291
, pp. 1730
-
-
Pischon, T.1
Girman, C.J.2
Hotamisligil, G.3
Rifai, N.4
Hu, F.B.5
Rimm, E.B.6
-
6
-
-
33748933358
-
Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men
-
Koenig W, Khuseyinova N, Baumert J, Meisinger C, Löwel H. Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men. J Am Coll Cardiol 2006: 48: 1369.
-
(2006)
J Am Coll Cardiol
, vol.48
, pp. 1369
-
-
Koenig, W.1
Khuseyinova, N.2
Baumert, J.3
Meisinger, C.4
Löwel, H.5
-
7
-
-
33749526844
-
Prevalence of metabolic syndrome in heart transplant patients: Role of previous cardiopathy and years since the procedure - The TRACA study
-
Cordero Fort A, Gavira JJ, Alegria-Barrero E et al. Prevalence of metabolic syndrome in heart transplant patients: Role of previous cardiopathy and years since the procedure - the TRACA study. J Heart Lung Transplant 2006: 25: 1192.
-
(2006)
J Heart Lung Transplant
, vol.25
, pp. 1192
-
-
Cordero, F.A.1
Gavira, J.J.2
Alegria-Barrero, E.3
-
8
-
-
0035337156
-
Metabolic abnormalities characteristic of dysmetabolic syndrome predict the development of transplant coronary artery disease
-
Valantine H, Rickenbacker P, Kemna M et al. Metabolic abnormalities characteristic of dysmetabolic syndrome predict the development of transplant coronary artery disease. Circulation 2001: 103: 2144.
-
(2001)
Circulation
, vol.103
, pp. 2144
-
-
Valantine, H.1
Rickenbacker, P.2
Kemna, M.3
-
9
-
-
20744442461
-
Features of the metabolic syndrome of hypertriglyceridemic waist and transplant coronary artery disease
-
Sénéchal M, Lemieux I, Beucler I et al. Features of the metabolic syndrome of hypertriglyceridemic waist and transplant coronary artery disease. J Heart Lung Transplant 2005: 24: 819.
-
(2005)
J Heart Lung Transplant
, vol.24
, pp. 819
-
-
Sénéchal, M.1
Lemieux, I.2
Beucler, I.3
-
10
-
-
33947674226
-
Interplay between systemic inflammation and markers of insulin resistance in cardiovascular prognosis after heart transplantation
-
Biadi O, Potena L, Fearon W et al. Interplay between systemic inflammation and markers of insulin resistance in cardiovascular prognosis after heart transplantation. J Heart Lung Transplant 2007: 26: 324.
-
(2007)
J Heart Lung Transplant
, vol.26
, pp. 324
-
-
Biadi, O.1
Potena, L.2
Fearon, W.3
-
12
-
-
0021813187
-
Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man
-
Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985: 28: 412.
-
(1985)
Diabetologia
, vol.28
, pp. 412
-
-
Matthews, D.R.1
Hosker, J.P.2
Rudenski, A.S.3
-
14
-
-
33751536048
-
Immunosuppressive drug-induced diabetes
-
Penfornis A, Kury-Paulin S. Immunosuppressive drug-induced diabetes. Diabetes Metab 2006: 32: 539.
-
(2006)
Diabetes Metab
, vol.32
, pp. 539
-
-
Penfornis, A.1
Kury-Paulin, S.2
-
15
-
-
33751504650
-
Leptin and adiponectin levels in middle-aged postmenopausal women: Associations with lifestyle habits, hormones, and inflammatory markers-a cross-sectional study
-
Rolland YM, Perry HM, Patrick P, Banks WA, Morley JE. Leptin and adiponectin levels in middle-aged postmenopausal women: Associations with lifestyle habits, hormones, and inflammatory markers-a cross-sectional study. Metabolism 2006: 55: 1630.
-
(2006)
Metabolism
, vol.55
, pp. 1630
-
-
Rolland, Y.M.1
Perry, H.M.2
Patrick, P.3
Banks, W.A.4
Morley, J.E.5
-
16
-
-
9144244319
-
Adiponectin as a biomarker of the metabolic syndrome
-
Ryo M, Nakamura T, Kihara S et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004: 68: 975.
-
(2004)
Circ J
, vol.68
, pp. 975
-
-
Ryo, M.1
Nakamura, T.2
Kihara, S.3
-
17
-
-
33750080744
-
Circulating adiponectin concentrations in patients with congestive heart failure
-
George J, Patal S, Wexler D et al. Circulating adiponectin concentrations in patients with congestive heart failure. Heart 2006: 92: 1420.
-
(2006)
Heart
, vol.92
, pp. 1420
-
-
George, J.1
Patal, S.2
Wexler, D.3
-
18
-
-
13444266619
-
Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function
-
Guebre-Egziabher F, Bernhard J, Funahashi T, Hadj-Aissa A, F ouque D. Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function. Nephrol Dial Transplant 2005: 20: 129.
-
(2005)
Nephrol Dial Transplant
, vol.20
, pp. 129
-
-
Guebre-Egziabher, F.1
Bernhard, J.2
Funahashi, T.3
Hadj-Aissa, A.4
Fouque, D.5
-
19
-
-
34447318485
-
Adiponectin and renal function, and implication as a risk of cardiovascular disease
-
Iwashima Y, Horio T, Kumada M et al. Adiponectin and renal function, and implication as a risk of cardiovascular disease. Am J Cardiol 2006: 98: 1603.
-
(2006)
Am J Cardiol
, vol.98
, pp. 1603
-
-
Iwashima, Y.1
Horio, T.2
Kumada, M.3
-
21
-
-
26244458678
-
Plasma adiponectin levels are associated with insulin resistance but do not predict future risk of coronary heart disease in women
-
Lawlor DA, Smith GB, Ebrahim S, Thompson C, Sattar N. Plasma adiponectin levels are associated with insulin resistance but do not predict future risk of coronary heart disease in women. J Clin Endocrinol Metab 2005: 90: 577.
-
(2005)
J Clin Endocrinol Metab
, vol.90
, pp. 577
-
-
Lawlor, D.A.1
Smith, G.B.2
Ebrahim, S.3
Thompson, C.4
Sattar, N.5
-
22
-
-
33746745255
-
Adiponectin and coronary heart disease. A prospective study and meta-analysis
-
Sattar N, Wannamethee G, Sarwar N et al. Adiponectin and coronary heart disease. A prospective study and meta-analysis. Circulation 2006: 114: 623.
-
(2006)
Circulation
, vol.114
, pp. 623
-
-
Sattar, N.1
Wannamethee, G.2
Sarwar, N.3
|